Google, IBM & Meta Certificates — All 10,000+ Courses at 40% Off
One annual plan covers every course and certificate on Coursera. 40% off for a limited time.
Get Full Access
Dartmouth Health Continuing Education for Professionals Home, Medicine Grand Rounds - Medical Consequences of Climate Change, 10/29/2021 8:00:00 AM - 10/29/2024 9:00:00 AM, Participants in Medicine Grand Rounds will be able to identify the most current treatment guidelines, innovations, and standards of practice, and apply them to improve the care of individual patients, promote health and wellness in the population, and achieve clinical quality and safety goals. These educational activities are grounded in principles of health equity, evidence based medicine, inter-professional teamwork, patient-centered care, and respect for human dignity.
Presenter
Douglas M. DeLong, MD, MACP, FRCP
Associate Clinical Professor of Medicine
Columbia University College of Physicians and Surgeons
Division of General Internal Medicine
Bassett Healthcare Network
About our Presenter
Dr. Douglas DeLong is the immediate past Chief of the Division of General Internal Medicine at Bassett Hospital in Cooperstown, New York and an Associate Clinical Professor of Medicine in the College of Physicians and Surgeons at Columbia University. He is the Emeritus past Chair of the American College of Physicians (ACP) Board of Regents, and former Chair of the ACP Board of Governors. He is a contributing author to multiple ACP position papers, including the 2016 Position Paper on Climate Change and Health.
Learning Outcome(s)
Participants will be able to discuss the evidence for climate change, its consequences for health of the population, and potential actions to mitigate and/or adapt to direct and indirect health related impacts.
Disclosure
The following activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported the following financial relationship(s)* with ineligible company(ies)**. All of the relevant financial relationships listed for these individuals have been mitigated.
* Richard I. Rothstein, MD ~ has research support from Fractyl and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this activity report NO financial relationship(s)* with any ineligible company(ies)**.
* A “financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).
** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
Presenter
Douglas M. DeLong, MD, MACP, FRCP
Associate Clinical Professor of Medicine
Columbia University College of Physicians and Surgeons
Division of General Internal Medicine
Bassett Healthcare Network
About our Presenter
Dr. Douglas DeLong is the immediate past Chief of the Division of General Internal Medicine at Bassett Hospital in Cooperstown, New York and an Associate Clinical Professor of Medicine in the College of Physicians and Surgeons at Columbia University. He is the Emeritus past Chair of the American College of Physicians (ACP) Board of Regents, and former Chair of the ACP Board of Governors. He is a contributing author to multiple ACP position papers, including the 2016 Position Paper on Climate Change and Health.
Learning Outcome(s)
Participants will be able to discuss the evidence for climate change, its consequences for health of the population, and potential actions to mitigate and/or adapt to direct and indirect health related impacts.
Disclosure
The following activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported the following financial relationship(s)* with ineligible company(ies)**. All of the relevant financial relationships listed for these individuals have been mitigated.
* Richard I. Rothstein, MD ~ has research support from Fractyl and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this activity report NO financial relationship(s)* with any ineligible company(ies)**.
* A “financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).
** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Bibliographic Material
See presentation for bibliographic sources to allow for further study.
